From Cannan Abbey
A new medicinal cannabis clinic and dispensary offering ‘Releaf’ to patients in need has opened its doors in Noosa Heads.
The Hastings Street location is Releaf Group’s second franchise to open in Queensland and has already received more than 100 new patient inquiries from the local community.
Gary Mackenzie, founder and chief executive officer of Releaf Group, said expansion into Queensland was prioritized due to high patient demand.
“We know there are thousands of Queenslanders who are looking for a multidisciplinary approach to healthcare and we’re excited to be able to offer that soon across our four new clinics,” he said.
“We chose Hastings Street as it is a popular tourist destination. It’s only a small site but I think it will be great for travelers and the Noosa community.”
Mr Mackenzie, a cancer survivor himself, used CBD oil three years ago and says he prefers it as a “safer”, non-addictive pain management option.
“Studies have shown promising results for a variety of other conditions ranging from sleep disorders to Parkinson’s disease, severe epilepsy and anxiety, with new research emerging almost daily,” he said.
Established in 2017, Releaf Group is Australia’s first specialist clinic and pharmacy group, established to simplify the consultation process and access to a range of medicines for patients in need.
Offering a fully integrated healthcare service, Releaf Clinics are multidisciplinary and offer a range of services including conventional medical services, medical cannabis prescription, pharmacy and a retail store selling dietary supplements and health foods.
“Only the medicines require a prescription, so we also stock therapeutic products that you can access without a prescription,” Mr Mackenzie said.
Since 2016, doctors have been able to supply medicinal cannabis to patients for certain medical conditions. Amendments to the Narcotic Drugs Act allowed both legally grown cannabis and the manufacture of medicinal cannabis products in Australia.
The Therapeutic Goods Administration (TGA) governs the Special Approval Scheme (SAS) which allows certain naturopaths access to therapeutic products not listed on the Australian Register of Therapeutic Goods (ARTG). The SAS provides a pathway for prescribers
Access to medical cannabis for individual patients on a case-by-case basis.
According to the TGA, as of June 30, 2021, the TGA has approved over 130,000 Category B SAS applications for unlicensed medicinal cannabis products, with numbers showing a steady monthly increase.
“While our physicians are trained in prescribing medicinal cannabis and our pharmacists are trained in its use, medicinal cannabis is only one possible therapeutic option for the patient’s medical condition and suitability is assessed on an individual basis in consultation with the physician,” said Mr. Mackenzie .
“Our doctors need to assess whether a person’s condition could be helped by medicinal cannabis.
“If someone is interested in seeing a doctor, it’s easy. You are welcome to contact the clinic and make an appointment.”
Releaf offers telemedicine consultations with clinicians via phone and video chat for those who don’t live near a clinic.
Find Releaf Clinics at Shop 2, 3-9 Hastings Street, Noosa Heads.
For more information on Releaf Clinics visit releafclinics.com.au